First meeting “Cystic echinococcosis in
Chile, update in alternatives for control and
diagnostics in animals and humans”
Author
dc.contributor.author
Rojas, Cristian A. Álvarez
Author
dc.contributor.author
Fredes Martínez, Fernando
Author
dc.contributor.author
Torres, Marisa
Author
dc.contributor.author
Acosta Jamett, Gerardo
Author
dc.contributor.author
Álvarez, Juan Francisco
Author
dc.contributor.author
Pavletic, Carlos
Author
dc.contributor.author
Paredes, Rodolfo
Author
dc.contributor.author
Cortés, Sandra
Admission date
dc.date.accessioned
2017-03-02T13:26:00Z
Available date
dc.date.available
2017-03-02T13:26:00Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Parasites & Vectors (2016) 9:502
es_ES
Identifier
dc.identifier.other
10.1186/s13071-016-1792-y
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/142916
Abstract
dc.description.abstract
This report summarizes the outcomes of a meeting on cystic echinococcosis (CE) in animals and humans in Chile
held in Santiago, Chile, between the 21st and 22nd of January 2016. The meeting participants included
representatives of the Departamento de Zoonosis, Ministerio de Salud (Zoonotic Diseases Department, Ministry of
Health), representatives of the Secretarias Regionales del Ministerio de Salud (Regional Department of Health,
Ministry of Health), Instituto Nacional de Desarrollo Agropecuario (National Institute for the Development of
Agriculture and Livestock, INDAP), Instituto de Salud Pública (National Institute for Public Health, ISP) and the
Servicio Agrícola y Ganadero (Animal Health Department, SAG), academics from various universities, veterinarians
and physicians. Current and future CE control activities were discussed. It was noted that the EG95 vaccine was
being implemented for the first time in pilot control programmes, with the vaccine scheduled during 2016 in two
different regions in the South of Chile. In relation to use of the vaccine, the need was highlighted for acquiring
good quality data, based on CE findings at slaughterhouse, previous to initiation of vaccination so as to enable
correct assessment of the efficacy of the vaccine in the following years. The current world’s-best-practice
concerning the use of ultrasound as a diagnostic tool for the screening population in highly endemic remote and
poor areas was also discussed.